Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma have?
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma has 482 citations in the OpenAlex counts ScholarIQ stores.
When was Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma published?
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma has 2010 year in the ScholarIQ index.
What is the open-access status of Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma?
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma has bronze oa status in the ScholarIQ index.
What is the DOI of Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma?
The DOI for Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma is on the source record.
What is the PMID of Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma?
The PMID for Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma is on the source record.
What is the OpenAlex record for Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma?
The OpenAlex for Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma is on the source record.